Current Environment:

Summary

The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.

Conditions

Angelman Syndrome

Recruitment Status

Recruiting

Detailed Description

The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ultimately improving the care of individuals with Angelman syndrome.

Eligibility Criteria

Inclusion Criteria:

Molecular diagnosis of Angelman syndrome

Exclusion Criteria:

Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment

Gender

All

Minimum Age

N/A

Maximum Age

N/A

Download Date

August 4, 2021

Principal Investigator

Wen-Hann Tan

Primary Contact Information

Wen-Hann Tan, BMBS

617-355 6394

wen-hann.tan@childrens.harvard.edu

Johnna O'Sullivan, BA

617-919-4800

Johnna.OSullivan@childrens.harvard.edu

For more information on this trial, visit clinicaltrials.gov.

Contact

For more information and to contact the study team: